Stock BICTF BIOCURE TECHNOLOGY INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Biocure Technology Inc. OTC Markets

Equities

BICTF

CA09075T1075

Uranium

Market Closed - OTC Markets
Other stock markets
 12:30:00 12/12/2023 GMT 		5-day change 1st Jan Change
0.07 USD -.--% Intraday chart for Biocure Technology Inc. -.--% -.--%
05-02 Biocure Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Biocure Technology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 46.46 20.84 27.48 13.86 1.089 1.41
Enterprise Value (EV) 1 48.09 24.36 31.42 17.49 1.133 1.448
P/E ratio -6.98 x -4.4 x -9.16 x -11.9 x -0.74 x -0.77 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -7.62 x -5.4 x -10.4 x -4.64 x -1.7 x -
EV / FCF -493 x -24.9 x -87.3 x -3.49 x 0.25 x -0.32 x
FCF Yield -0.2% -4.02% -1.15% -28.6% 405% -317%
Price to Book 51.6 x -71.7 x -13.7 x -26 x -0.55 x 0.88 x
Nbr of stocks (in thousands) 96,793 96,937 99,915 106,621 108,921 94,001
Reference price 2 0.4800 0.2150 0.2750 0.1300 0.0100 0.0150
Announcement Date 30/04/19 29/04/20 30/04/21 29/04/22 16/05/23 02/05/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - - - - - -
EBITDA 1 -6.313 -4.512 -3.022 -3.769 -0.6676 -
EBIT 1 -6.365 -4.557 -3.067 -3.833 -0.6737 -1.052
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -6.586 -4.791 -3.078 -1.148 -0.4034 -1.494
Net income 1 -6.586 -4.74 -2.946 -1.128 -1.45 -1.814
Net margin - - - - - -
EPS 2 -0.0688 -0.0489 -0.0300 -0.0109 -0.0136 -0.0195
Free Cash Flow 1 -0.0976 -0.9788 -0.36 -5.01 4.588 -4.583
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 30/04/19 29/04/20 30/04/21 29/04/22 16/05/23 02/05/24
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 1.63 3.52 3.94 3.63 0.04 0.04
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -0.2588 x -0.7797 x -1.305 x -0.9632 x -0.0652 x -
Free Cash Flow 1 -0.1 -0.98 -0.36 -5.01 4.59 -4.58
ROE (net income / shareholders' equity) -348% -1,979% 225% 72.5% 25.4% 413%
ROA (Net income/ Total Assets) -106% -69.5% -42% -55.1% -13.5% -32.4%
Assets 1 6.211 6.823 7.012 2.049 10.74 5.598
Book Value Per Share 2 0.0100 -0 -0.0200 -0 -0.0200 0.0200
Cash Flow per Share 2 0 0 0 0 0 0
Capex 1 0.04 - 0 0 - -
Capex / Sales - - - - - -
Announcement Date 30/04/19 29/04/20 30/04/21 29/04/22 16/05/23 02/05/24
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Uranium

1st Jan change Capi.
CAMECO CORPORATION Stock Cameco Corporation
+17.21% 21.27B
URANIUM ENERGY CORP. Stock Uranium Energy Corp.
+7.81% 2.79B
CGN MINING COMPANY LIMITED Stock CGN Mining Company Limited
+48.26% 2.36B
YELLOW CAKE PLC Stock Yellow Cake plc
+10.75% 1.85B
BOSS ENERGY LIMITED Stock Boss Energy Limited
+40.45% 1.54B
CENTRUS ENERGY CORP. Stock Centrus Energy Corp.
-20.25% 694M
URANIUM ROYALTY CORP. Stock Uranium Royalty Corp.
-3.09% 303M
ELEVATE URANIUM LTD Stock Elevate Uranium Ltd
+16.85% 107M
GOVIEX URANIUM INC. Stock GoviEx Uranium Inc.
-26.67% 65.33M
Other Uranium
  1. Stock Market
  2. Equities
  3. CURE Stock
  4. BICTF Stock
  5. Financials Biocure Technology Inc.